TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biovica International AB
Closing information (x1000 SEK)
| Closing information | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Turnover |
8,619
|
7,290
|
3,383 |
| Financial expenses |
1,139
|
289
|
493 |
| Earnings before taxes |
-85,983
|
-124,136
|
-110,680 |
| EBITDA |
-76,996
|
-117,416
|
-102,243 |
| Total assets |
64,949
|
131,408
|
172,288 |
| Current assets |
30,794
|
88,115
|
119,990 |
| Current liabilities |
18,158
|
28,291
|
23,638 |
| Equity capital |
43,206
|
96,641
|
138,636 |
| - share capital |
6,519
|
5,604
|
3,049 |
| Employees (average) |
26
|
37
|
31 |
Financial ratios
| Fiscal year | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Solvency |
66.5%
|
73.5%
|
80.5% |
| Turnover per employee |
332
|
197
|
109 |
| Profit as a percentage of turnover |
-997.6%
|
-1702.8%
|
-3271.7% |
| Return on assets (ROA) |
-130.6%
|
-94.2%
|
-64.0% |
| Current ratio |
169.6%
|
311.5%
|
507.6% |
| Return on equity (ROE) |
-199.0%
|
-128.5%
|
-79.8% |
| Change turnover |
1,329
|
3,907
|
1,338 |
| Change turnover % |
18%
|
115%
|
65% |
| Chg. No. of employees |
-11
|
6
|
6 |
| Chg. No. of employees % |
-30%
|
19%
|
24% |
Total value of public sale
| Fiscal year | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.